solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
GEMFIBROZIL |
Adrenergic, Norepinephrine Transporter |
-19% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
BENZYL ALCOHOL |
CYP450-1A2 Inhibition |
-19% |
NoneNone |
NoneNone |
View
|
A3 adenosine receptor |
ENALAPRIL |
Adenosine A3 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
MIFEPRISTONE |
Serotonin 5-HT2B |
-19% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase, second type |
GEMFIBROZIL |
Lipoxygenase 15-LO |
-19% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
GEMFIBROZIL |
Lipoxygenase 15-LO |
-19% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
GEMFIBROZIL |
Lipoxygenase 15-LO |
-19% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
ENALAPRIL |
Dopamine D2L |
-19% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
KETOROLAC |
Monoamine Oxidase MAOA |
-19% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
KETOROLAC |
Monoamine Oxidase MAOA |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
KETOROLAC |
GABAA, Agonist Site |
-19% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
ETHINYLESTRADIOL |
Protein Serine/Threonine Kinase, ERK2 |
-19% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
ETHINYLESTRADIOL |
Protein Serine/Threonine Kinase, ERK2 |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
KETOROLAC |
Muscarinic M3 |
-19% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
METOPROLOL |
Leukotriene C4 Synthetase |
-19% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
METOPROLOL |
Leukotriene C4 Synthetase |
-19% |
NoneNone |
NoneNone |
View
|
platelet-activating factor receptor |
METOPROLOL |
Platelet Activating Factor (PAF) |
-19% |
NoneNone |
NoneNone |
View
|
insulin receptor |
AZAURIDINE |
Insulin |
-19% |
NoneNone |
NoneNone |
View
|
insulin receptor |
AZAURIDINE |
Insulin |
-19% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
AJMALINE |
CYP450-2C9 Inhibition |
-19% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
AJMALINE |
CYP450-2C9 Inhibition |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
MESTRANOL |
Muscarinic M5 |
-19% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
BETAMETHASONE |
HMG-CoA Reductase |
-19% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
BETAMETHASONE |
HMG-CoA Reductase |
-19% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
BETAMETHASONE |
Neuropeptide Y1 |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
ATRACTYLOSIDE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
ATRACTYLOSIDE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
ATRACTYLOSIDE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
ATRACTYLOSIDE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
ATRACTYLOSIDE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
PRAZOSIN |
Atrial Natriuretic Factor (ANF) |
-19% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 3 |
PRAZOSIN |
Atrial Natriuretic Factor (ANF) |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
OXCARBAZEPINE |
Sodium Channel, Site 2 |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
PRALIDOXIME CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
-19% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 1, member B4 (aldose reductase) |
LEVOBUNOLOL |
Aldose Reductase |
-19% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
LEVOBUNOLOL |
Aldose Reductase |
-19% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
LEVOBUNOLOL |
Aldose Reductase |
-19% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
LEVOBUNOLOL |
Aldose Reductase |
-19% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
FLUVASTATIN |
Leukotriene C4 Synthetase |
-19% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
FLUVASTATIN |
Leukotriene C4 Synthetase |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
LORAZEPAM |
Adrenergic alpha2B |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
SODIUM NITROPRUSSIDE |
Phosphodiesterase PDE5 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
SODIUM NITROPRUSSIDE |
Phosphodiesterase PDE5 |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
METOCLOPRAMIDE |
Glutamate, Kainate |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
METOCLOPRAMIDE |
Glutamate, Kainate |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
METOCLOPRAMIDE |
Glutamate, Kainate |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
METOCLOPRAMIDE |
Glutamate, Kainate |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
METOCLOPRAMIDE |
Glutamate, Kainate |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
TROGLITAZONE |
Chemokine CXCR1(IL-8A) |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
HYDROCHLOROTHIAZIDE |
Serotonin 5-HT4 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
HYDROCHLOROTHIAZIDE |
Serotonin 5-HT4 |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1b |
DEXIBUPROFEN |
Adrenergic alpha1B |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
PIMARICIN |
Glutamate, AMPA |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
PIMARICIN |
Glutamate, AMPA |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
PIMARICIN |
Glutamate, AMPA |
-19% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
PIMARICIN |
Glutamate, AMPA |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
OUABAIN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
OUABAIN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
OUABAIN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
OUABAIN |
Glycine, Strychnine-Sensitive |
-19% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
BENZO[A]PYRENE |
Dopamine Transporter |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
CIGLITAZONE |
Adrenergic alpha2C |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
CIGLITAZONE |
Adrenergic alpha2C |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
TOBRAMYCIN |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
TOBRAMYCIN |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
ALPHA-TOCOPHEROL |
Purinergic P2X |
-19% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
ALPHA-TOCOPHEROL |
Purinergic P2X |
-19% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
ALPHA-TOCOPHEROL |
Purinergic P2X |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
PREDNISOLONE |
Adrenergic beta1 |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
PREDNISOLONE |
Adrenergic beta1 |
-19% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
AZATHIOPRINE |
Dopamine Transporter |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
AZATHIOPRINE |
Adrenergic alpha2A |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
LEVAMISOLE |
Adrenergic beta2 |
-19% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
LEVAMISOLE |
Calcitonin |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
SIMVASTATIN |
Serotonin 5-HT2C |
-19% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
LY-294002 |
beta-Lactamase |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CARBOPLATIN |
Calcium Channel Type L, Dihydropyridine |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
10,11-DIHYDRO-CARBAMAZEPINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
10,11-DIHYDRO-CARBAMAZEPINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
10,11-DIHYDRO-CARBAMAZEPINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
10,11-DIHYDRO-CARBAMAZEPINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
10,11-DIHYDRO-CARBAMAZEPINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
10,11-DIHYDRO-CARBAMAZEPINE |
Nicotinic Acetylcholine, Central |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
COBALT(II) ACETYLACETONATE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
COBALT(II) ACETYLACETONATE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
DIHYDROERGOCRISTINE MESYLATE |
Chemokine CXCR1(IL-8A) |
-19% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
CARBOPLATIN |
Monoamine Oxidase MAOA |
-19% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
CARBOPLATIN |
Monoamine Oxidase MAOA |
-19% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
DIHYDROERGOCRISTINE MESYLATE |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
DIHYDROERGOCRISTINE MESYLATE |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
DIHYDROERGOCRISTINE MESYLATE |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
DIHYDROERGOCRISTINE MESYLATE |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
PUROMYCIN |
Vasoactive Intestinal Peptide VIP1 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
CARBOXYMETHYLCELLULOSE |
Serotonin 5-HT3 |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
CARBOXYMETHYLCELLULOSE |
Serotonin 5-HT3 |
-19% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
TERCONAZOLE |
beta-Lactamase |
-19% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
SULINDAC SULFONE |
Dopamine D3 |
-19% |
NoneNone |
NoneNone |
View
|
insulin receptor |
TACRINE |
Insulin |
-19% |
NoneNone |
NoneNone |
View
|
insulin receptor |
TACRINE |
Insulin |
-19% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
TORSEMIDE |
Interleukin IL-1 alpha |
-19% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
ROSIGLITAZONE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-19% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
ROSIGLITAZONE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
TETRACYCLINE |
Serotonin 5-HT1B |
-19% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
TEGAFUR |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
TEGAFUR |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
TEGAFUR |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
TEGAFUR |
Platelet-Derived Growth Factor (PDGF) |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
METERGOLINE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
METERGOLINE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
TEGAFUR |
Protein Serine/Threonine Kinase PKCalpha |
-19% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
TEGAFUR |
Protein Serine/Threonine Kinase PKCalpha |
-19% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
6-MERCAPTOPURINE |
Protein Serine/Threonine Kinase, p38alpha |
-19% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
6-MERCAPTOPURINE |
Protein Serine/Threonine Kinase, p38alpha |
-19% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
PRAZIQUANTEL |
Vascular Endothelinal Growth Factor (VEGF) |
-19% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
PRAZIQUANTEL |
Vascular Endothelinal Growth Factor (VEGF) |
-19% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
6-MERCAPTOPURINE |
Monoamine Oxidase MAOA |
-19% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
6-MERCAPTOPURINE |
Monoamine Oxidase MAOA |
-19% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
PENTOXIFYLLINE |
Protein Tyrosine Kinase, HER2 Receptor |
-19% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
PENTOXIFYLLINE |
Protein Tyrosine Kinase, HER2 Receptor |
-19% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
PRILOCAINE |
Serotonin Transporter |
-19% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
PRAZOSIN |
Atrial Natriuretic Factor (ANF) |
-19% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
CLOSANTEL |
Purinergic P2X |
-19% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
CLOSANTEL |
Purinergic P2X |
-19% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
DICHLORVOS |
Calcitonin |
-19% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 5 (DBSS) |
DACTINOMYCIN |
Tumor Necrosis Factor (TNF), Non-Selective |
-19% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1b |
DACTINOMYCIN |
Tumor Necrosis Factor (TNF), Non-Selective |
-19% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1a |
DACTINOMYCIN |
Tumor Necrosis Factor (TNF), Non-Selective |
-19% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 4 |
DACTINOMYCIN |
Tumor Necrosis Factor (TNF), Non-Selective |
-19% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
DACTINOMYCIN |
Tumor Necrosis Factor (TNF), Non-Selective |
-19% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
DACTINOMYCIN |
Tumor Necrosis Factor (TNF), Non-Selective |
-19% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
ETHYLESTRENOL |
Serotonin 5-HT1A |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
MOXONIDINE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
MOXONIDINE |
Phosphodiesterase PDE3 |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
GRAMICIDIN |
Imidazoline I2, Central |
-19% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
GRAMICIDIN |
Imidazoline I2, Central |
-19% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
RIFABUTIN |
Leukotriene B4 |
-19% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
RIFABUTIN |
Leukotriene B4 |
-19% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
RIFABUTIN |
Leukotriene B4 |
-19% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
RIFABUTIN |
Leukotriene B4 |
-19% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
BUSPIRONE |
Atrial Natriuretic Factor (ANF) |
-19% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
BUSPIRONE |
Atrial Natriuretic Factor (ANF) |
-19% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 3 |
BUSPIRONE |
Atrial Natriuretic Factor (ANF) |
-19% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
LISURIDE |
Vascular Endothelinal Growth Factor (VEGF) |
-19% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
LISURIDE |
Vascular Endothelinal Growth Factor (VEGF) |
-19% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
OXCARBAZEPINE |
Sodium Channel, Site 2 |
-19% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
OXCARBAZEPINE |
Sodium Channel, Site 2 |
-19% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
OXCARBAZEPINE |
Sodium Channel, Site 2 |
-19% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
OXCARBAZEPINE |
Sodium Channel, Site 2 |
-19% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
OXCARBAZEPINE |
Sodium Channel, Site 2 |
-19% |
NoneNone |
NoneNone |
View
|